A recent study indicates that people who come off popular slimming jabs like semaglutide or tirzepatide can put back on lost weight at a significantly accelerated pace than those who stop traditional lifestyle regimens.
Published data in a leading health publication points out that while overweight individuals frequently drop a large proportion of their body weight while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month once they quit.
"Users using such treatments must be cognizant of the potential of quick rebound weight gain when the medication is stopped," warns expert Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment mass within about one and a half years.
Comparing Treatments
The study, which reviewed dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with other pills.
Scientists emphasize that individuals who lose weight through dieting generally have a slower creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Quick Regain
Experts propose the mechanism of the drugs explains the heightened weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Sustained high doses of GLP-1 concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this GLP-1 'fix' means appetite is no longer kept in check, making excessive eating far more likely."
A Lifelong Issue?
Health authorities suggest the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.
Many experts argue that, considering the likelihood of relapse, the treatment is often long-term.
This view is echoed by pharmaceutical companies, who note that the results "emphasize the chronic nature of excess weight," akin to managing diseases like high blood pressure.
User Accounts
People who have come off the medication report a sudden resurgence of hunger.
"It was like a trigger activating and you're instantly starving," described one woman.
The struggle is worsened if patients have not adopted lasting lifestyle or habit modifications during treatment.
Widespread Interest
Figures show that a significant number of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is higher among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians caution that while GLP-1 drugs are effective tools for weight loss, they are not a standalone solution and long-term success relies on integrated lifestyle management.
